SICKLE CELL DISEASE (SCD)
Clinical trials for SICKLE CELL DISEASE (SCD) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL DISEASE (SCD) trials appear
Sign up with your email to follow new studies for SICKLE CELL DISEASE (SCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for kids with sickle cell: drug shows promise in cutting painful episodes
Disease control CompletedThis study tested the safety and proper dosing of a drug called crizanlizumab in children aged 2 to 18 with sickle cell disease who have had painful vaso-occlusive crises. The drug, already shown to work in adults, aims to reduce these painful events. Over two years, researchers …
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New drug shows promise in reducing painful sickle cell crises
Disease control CompletedThis study looked at the safety of a drug called crizanlizumab in 140 Indian patients aged 16 and older with sickle cell disease who have had painful crises. The drug is meant to reduce the frequency of these crises. Researchers monitored serious side effects and other adverse ev…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
ER wait after admission costs millions, study finds
Knowledge-focused CompletedThis study looked at over 30,000 adults admitted to hospitals in Maryland to understand why some patients wait in the emergency room even after being admitted (called boarding). Researchers wanted to find out which patients are more likely to board, how boarding increases healthc…
Matched conditions: SICKLE CELL DISEASE (SCD)
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 26, 2026 06:00 UTC